Dr. Edgar Diaz-Cruz, assistant professor of Pharmacy, was recently published in the journal. Frontiers in Oncology, for research he and his colleagues conducted on human pancreatic cancer.   The study, entitled Human pancreatic cancer-associated stellate cells remain activated after in vivo chemoradiation, showed that human tumor-derived pancreatic stellate cells survive both in vivo chemo- and radiotherapy. The data supports the idea that stellate cells play an essential role in supporting and promoting pancreatic cancer and may lead to new treatments targeting the pancreatic tumor microenvironment.  The team included researchers from the National Cancer Informatics Program, the Lombardi Comprehensive Cancer Center, Georgetown University, the University of Texas, the German Research Center for Environmental Health, and ETH Zurich in Switzerland.